摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-<(1R,3R,4R)-3-methyl-2,5-diazabicyclo<2.2.1>heptan2-yl>-1-(1,1-dimethylethyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid | 141621-17-2

中文名称
——
中文别名
——
英文名称
7-<(1R,3R,4R)-3-methyl-2,5-diazabicyclo<2.2.1>heptan2-yl>-1-(1,1-dimethylethyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid
英文别名
1-tert-butyl-6-fluoro-7-[(1R,3R,4R)-3-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]-4-oxo-1,8-naphthyridine-3-carboxylic acid
7-<(1R,3R,4R)-3-methyl-2,5-diazabicyclo<2.2.1>heptan2-yl>-1-(1,1-dimethylethyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid化学式
CAS
141621-17-2
化学式
C19H23FN4O3
mdl
——
分子量
374.415
InChiKey
HARIOISNLHCOKD-GPCCPHFNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    27
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    85.8
  • 氢给体数:
    2
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Preparation of (6R)- and (6S)-(1R,4R)-6-Methyl-2-(p-toluenesulfonyl)-5-phenylmethyl-2,5-diazabicyclo[2.2.1]heptanes, Intermediates in a Synthesis of New Quinolones
    作者:Philippe Remuzon、Daniel Bouzard、Christian Dussy、Jean-Pierre Jacquet、Massoud Massoudi
    DOI:10.3987/com-91-5925
    日期:——
    An efficient chiral synthesis of both diastereoisomers (2a) and (2b) was performed using trans-4-hydroxy-L-proline as starting material. These bridged piperazines were used in the preparation of quinolones.
  • Fluoronaphthyridines as antibacterial agents. 6. Synthesis and structure-activity relationships of new chiral 7-(1-, 3-, 4-, and 6-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)naphthyridine analogs of 7-[(1R,4R)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-1-(1,1-dimethylethyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid. Influence of the configuration on blood pressure in dogs. A quinolone-class effect
    作者:Philippe Remuzon、Daniel Bouzard、Chantal Guiol、Jean Pierre Jacquet
    DOI:10.1021/jm00093a024
    日期:1992.7
    acid (1a) (BMY 40062). The derivatives 7-[(1R,4R,6S)-6-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl]- 1-(1,1-dimethylethyl)-6-fluro-1,4-dihydro-4-oxo-1,8-naphthyridine- 3-carboxylic acid (41) and 7-[(1R,4R,6S)-6-methyl-2,5-diazabicyclo[2.2.1]heptan-2- yl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxy lic acid (49) showed potent in vitro and in vivo antibacterial activity against Gram-positive
    8-萘啶-3-羧酸(49)对革兰氏阳性和革兰氏阴性细菌表现出强大的体外和体内抗菌活性。与狗1a静脉输注后相比,衍生物49与1a相比,血压(MAP)下降幅度较小,并被选作临床前试验的潜在候选者。
查看更多